Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the UBS Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, ...

Wednesday, April 20, 2022 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: NEW BRUNSWICK, N.J. , April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24 th . Mathai Mammen , Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at
Price reaction · baseline $183.08 (2022-04-19 close) · hit after-hours · 1 other JNJ headline(s) in the window, move may be shared
day 0 close
+0.4%

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24 th . Mathai Mammen , Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48 hours after the live webcast.
ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 20, 2022

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CanagliflozinPhase 3
Diabetes Mellitus, Type 2 →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →